Broker notes, analysis and comments
Allergy Therapeutics Plc (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. Pollinex Quattro continues to gain market share despite being available in EU only on..
Mi-Pay Group plc (LON:MPAY), the leading provider of mobile payment solutions to Tier 1 Mobile Network Operators and Mobile Virtual Network Operators, presents today its final results for the 12..
Flowtech Fluidpower plc (LON:FLOW) today issued the following unaudited Trading Update covering the period from 1 January 2017 to the date of this announcement. The financial reporting period covers the..
Although Redx Pharma Plc (LON:REDX) has only been operational since late-2010, it has already discovered several valuable drug candidates, the first of which is about to begin clinical trials. Although..
Elegant Hotels PLC (LON:EHG) has this morning announced it has entered into a conditional agreement to acquire the issued share capital of Treasure Beach Ltd, including the business, the freehold..
This morning ITM Power PLC (LON:ITM) put out a seminal RNS announcement. It is the first multi-MW commercial deal signed by the company; 3MW of electrolysis hardware with some ancillary..
SigmaRoc plc (LON:SRC) has established a new bulk-shipping subsidiary to support the material importation requirements of its Ronez vertically-integrated aggregates business on the Channel Islands. The initiative includes the £0.55m..
Oxford BioMedica plc (LON:OXB) is a specialist gene and cell therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, whilst retaining its own proprietary therapeutic candidates. Above service-fees,..
On March 9th Ilika plc (LON:IKA) announced a $1m deal with its established blue chip partner Toyota Motor Corp (TYO:7203) in ‘a new application area’. Yesterday’s RNS reveals, via an..
DX (Group) plc (LON:DX) has announced that it is in discussion on a potential combination with the Distribution division of John Menzies. The proposed transaction would see DX acquire Menzies..
Entu (UK) plc (LON:ENTU) final results in line with expectations following a challenging year that has included significant divisional restructuring, and a detailed balance sheet and accounting policy review. EBITDA..
Allergy Therapeutics Plc (LON:AGY) the UK-based, specialty pharmaceutical company focused on the development, manufacture and sale of vaccines and other products for the treatment and prevention of allergies, today reported..
Arbuthnot Banking Group Plc (LON:ARBB) strategy, and largely the same management team, have delivered total shareholder returns of 418% 2008-2017 and 930% 1997-2017 respectively. 2016 saw a new phase in..
What’s new? Mortgage Advice Bureau (Holdings) Plc (LON:MAB1) full year results for the year to 31 December 2016 are marginally ahead of the detailed pre-close statement released on 27 January...
Diurnal Group Plc (LON:DNL) is a clinical stage specialty pharmaceutical company focused on diseases of the endocrine system. Its two lead candidates are targeted at rare diseases with unmet medical..
ITM Power Plc (LON:ITM) announced this morning that it has completed the sale of a 0.5MW electrolyser with some associated ancillary hydrogen energy hardware to a customer for £0.73m. No..
Following Inchcape PLC (LON:INCH) results earlier this month, we publish our new forecasts following the segmental consolidation of divisions, and remain cautious relative to consensus (c.2% below at the PBT..
Safestyle UK plc (LON:SFE) pre-close trading statement in January had already stated that the FY16 revenue outcome was a record £163.1m (FY15: £148.9m) and indicated that profitability was in line..
Avacta Group Plc (LON:AVCT) is the proprietary owner of Affimer technology for the development of bio-therapeutics, diagnostic tests and research reagents. Affimers represent a radical alternative to established antibody technology..
Burford Capital Limited (LON:BUR) results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional..
